Author:
Sundaram S. Mohana,Varier Lavanya,Fathima Khan Zahara,Dharmarajan Arun,Warrier Sudha
Funder
University Grants Commission
Department of Biotechnology, Ministry of Science and Technology, India
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference69 articles.
1. Ovarian cancer in the world: epidemiology and risk factors;Momenimovahed;Int. J. Women's Health,2019
2. Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy;Romero,2012
3. Chemotherapy resistance in advanced ovarian cancer patients;Pokhriyal;Biomark.Cancer,2019
4. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group);McGuire;Semin. Oncol.,1996
5. Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group;Pfisterer;Gynecol. Oncol.,2004
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献